CN113244438B - 一种三维糖尿病足溃疡功能性医用敷料的制备方法 - Google Patents
一种三维糖尿病足溃疡功能性医用敷料的制备方法 Download PDFInfo
- Publication number
- CN113244438B CN113244438B CN202110475981.5A CN202110475981A CN113244438B CN 113244438 B CN113244438 B CN 113244438B CN 202110475981 A CN202110475981 A CN 202110475981A CN 113244438 B CN113244438 B CN 113244438B
- Authority
- CN
- China
- Prior art keywords
- diabetic foot
- foot ulcer
- medical dressing
- functional medical
- dimensional
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 208000008960 Diabetic foot Diseases 0.000 title claims abstract description 54
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 239000010410 layer Substances 0.000 claims abstract description 38
- 239000012071 phase Substances 0.000 claims abstract description 36
- 238000007639 printing Methods 0.000 claims abstract description 11
- 238000010146 3D printing Methods 0.000 claims abstract description 10
- 239000008385 outer phase Substances 0.000 claims abstract description 8
- 239000012792 core layer Substances 0.000 claims abstract description 5
- 239000008384 inner phase Substances 0.000 claims abstract description 4
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 36
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 36
- 239000000243 solution Substances 0.000 claims description 32
- 229920001661 Chitosan Polymers 0.000 claims description 21
- 239000007864 aqueous solution Substances 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 18
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 claims description 16
- 229920000642 polymer Polymers 0.000 claims description 11
- 239000003814 drug Substances 0.000 claims description 10
- 229960000905 indomethacin Drugs 0.000 claims description 9
- -1 thianaphthenate Chemical compound 0.000 claims description 6
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 5
- 229940072056 alginate Drugs 0.000 claims description 5
- 235000010443 alginic acid Nutrition 0.000 claims description 5
- 229920000615 alginic acid Polymers 0.000 claims description 5
- CNBGNNVCVSKAQZ-UHFFFAOYSA-N benzydamine Chemical compound C12=CC=CC=C2C(OCCCN(C)C)=NN1CC1=CC=CC=C1 CNBGNNVCVSKAQZ-UHFFFAOYSA-N 0.000 claims description 4
- 230000003637 steroidlike Effects 0.000 claims description 4
- 230000000202 analgesic effect Effects 0.000 claims description 3
- FSQKKOOTNAMONP-UHFFFAOYSA-N acemetacin Chemical compound CC1=C(CC(=O)OCC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 FSQKKOOTNAMONP-UHFFFAOYSA-N 0.000 claims description 2
- 229960004892 acemetacin Drugs 0.000 claims description 2
- 229960000333 benzydamine Drugs 0.000 claims description 2
- 239000011259 mixed solution Substances 0.000 claims description 2
- 229920001610 polycaprolactone Polymers 0.000 claims description 2
- 239000004632 polycaprolactone Substances 0.000 claims description 2
- 229920002635 polyurethane Polymers 0.000 claims description 2
- 239000004814 polyurethane Substances 0.000 claims description 2
- 229960001017 tolmetin Drugs 0.000 claims description 2
- UPSPUYADGBWSHF-UHFFFAOYSA-N tolmetin Chemical compound C1=CC(C)=CC=C1C(=O)C1=CC=C(CC(O)=O)N1C UPSPUYADGBWSHF-UHFFFAOYSA-N 0.000 claims description 2
- 229940035676 analgesics Drugs 0.000 claims 1
- 239000000730 antalgic agent Substances 0.000 claims 1
- 229940121386 matrix metalloproteinase inhibitor Drugs 0.000 claims 1
- 239000003771 matrix metalloproteinase inhibitor Substances 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 11
- 229920001410 Microfiber Polymers 0.000 abstract description 8
- 239000003658 microfiber Substances 0.000 abstract description 8
- 230000008961 swelling Effects 0.000 abstract description 7
- 238000010521 absorption reaction Methods 0.000 abstract description 5
- 239000002131 composite material Substances 0.000 abstract 1
- 206010052428 Wound Diseases 0.000 description 13
- 208000027418 Wounds and injury Diseases 0.000 description 13
- 241000588724 Escherichia coli Species 0.000 description 10
- 230000001580 bacterial effect Effects 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 241000894006 Bacteria Species 0.000 description 8
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 8
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 8
- 241000191967 Staphylococcus aureus Species 0.000 description 7
- 239000000835 fiber Substances 0.000 description 7
- 230000035876 healing Effects 0.000 description 7
- 239000003112 inhibitor Substances 0.000 description 7
- 230000005764 inhibitory process Effects 0.000 description 7
- 230000002572 peristaltic effect Effects 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 230000015556 catabolic process Effects 0.000 description 6
- 238000006731 degradation reaction Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 235000010413 sodium alginate Nutrition 0.000 description 6
- 239000000661 sodium alginate Substances 0.000 description 6
- 229940005550 sodium alginate Drugs 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- 238000001069 Raman spectroscopy Methods 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 239000004698 Polyethylene Substances 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 229920003023 plastic Polymers 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 229920000573 polyethylene Polymers 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 238000009987 spinning Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 230000006399 behavior Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000000704 physical effect Effects 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 2
- 238000002266 amputation Methods 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 208000022362 bacterial infectious disease Diseases 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000012452 mother liquor Substances 0.000 description 2
- 230000001172 regenerating effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000003260 vortexing Methods 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000282414 Homo sapiens Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000009979 Traumatic Amputation Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001804 debridement Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000001700 effect on tissue Effects 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 239000000416 hydrocolloid Substances 0.000 description 1
- 238000002639 hyperbaric oxygen therapy Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000009323 psychological health Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 239000012209 synthetic fiber Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000001364 upper extremity Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/24—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B33—ADDITIVE MANUFACTURING TECHNOLOGY
- B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- B33Y10/00—Processes of additive manufacturing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B33—ADDITIVE MANUFACTURING TECHNOLOGY
- B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- B33Y70/00—Materials specially adapted for additive manufacturing
- B33Y70/10—Composites of different types of material, e.g. mixtures of ceramics and polymers or mixtures of metals and biomaterials
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B33—ADDITIVE MANUFACTURING TECHNOLOGY
- B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- B33Y80/00—Products made by additive manufacturing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/216—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/432—Inhibitors, antagonists
- A61L2300/434—Inhibitors, antagonists of enzymes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Life Sciences & Earth Sciences (AREA)
- Manufacturing & Machinery (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Ceramic Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Structural Engineering (AREA)
- Composite Materials (AREA)
- Civil Engineering (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (11)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110475981.5A CN113244438B (zh) | 2021-04-29 | 2021-04-29 | 一种三维糖尿病足溃疡功能性医用敷料的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110475981.5A CN113244438B (zh) | 2021-04-29 | 2021-04-29 | 一种三维糖尿病足溃疡功能性医用敷料的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113244438A CN113244438A (zh) | 2021-08-13 |
CN113244438B true CN113244438B (zh) | 2022-05-17 |
Family
ID=77223647
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110475981.5A Active CN113244438B (zh) | 2021-04-29 | 2021-04-29 | 一种三维糖尿病足溃疡功能性医用敷料的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113244438B (zh) |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2471522B (en) * | 2009-07-03 | 2014-01-08 | Cambridge Entpr Ltd | Microfluidic devices |
CN103132163B (zh) * | 2013-03-12 | 2016-01-27 | 东南大学 | 一种具有多重核壳结构的纤维的制备方法 |
CN103611182B (zh) * | 2013-12-10 | 2015-05-13 | 东华大学 | 一种医用敷料用核-壳结构超细纤维载体材料的制备方法 |
WO2016172707A1 (en) * | 2015-04-24 | 2016-10-27 | The Board Of Trustees Of The University Of Illinois | Methods of extruding multilayer fibers |
CN105031713A (zh) * | 2015-08-27 | 2015-11-11 | 华南理工大学 | 一种3d生物打印的医用敷料及其制备方法 |
ES2959245T3 (es) * | 2016-10-28 | 2024-02-22 | Cellink Bioprinting Ab | Preparación y aplicaciones de biotintas para bioimpresión 3D para la reparación de defectos óseos, a base de hidrogeles de nanofibrillas de celulosa con partículas de fosfato de calcio natural o sintético |
CN106620811A (zh) * | 2016-11-16 | 2017-05-10 | 陕西品达石化有限公司 | 一种采用静电纺丝法制备纳米纤维敷料的方法 |
US11702623B2 (en) * | 2017-05-11 | 2023-07-18 | King Abdullah University Of Science And Technology | Device and method for microfluidics-based 3D bioprinting |
US10973775B2 (en) * | 2017-09-22 | 2021-04-13 | University Of Manitoba | Antibacterial nanofiber |
CN109381703A (zh) * | 2018-11-27 | 2019-02-26 | 五邑大学 | 海藻酸钙纳米纤维及制备方法和应用、载药海藻酸钙纳米纤维及制备方法 |
CN109394736B (zh) * | 2018-11-27 | 2022-04-12 | 五邑大学 | 层层自组装纳米纤维药物载体及制备方法、层层自组装载药纳米纤维及制备方法 |
KR102129373B1 (ko) * | 2019-01-08 | 2020-07-03 | 성균관대학교산학협력단 | 모세혈관망을 포함하는 3차원 소장 융모 모사 구조체의 제조방법 |
CN110257243B (zh) * | 2019-07-23 | 2021-06-25 | 清华大学深圳研究生院 | 微流控芯片打印喷嘴和生物3d打印系统 |
CN111000863A (zh) * | 2019-12-20 | 2020-04-14 | 中国人民解放军东部战区总医院 | 封装烟酸金属有机骨架的水凝胶微胶囊及其制备方法和应用 |
CN112692303B (zh) * | 2020-12-14 | 2022-06-21 | 江苏大学 | 一种微流控3d打印复合材料制备装置及方法 |
-
2021
- 2021-04-29 CN CN202110475981.5A patent/CN113244438B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN113244438A (zh) | 2021-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zhu et al. | Continuous self‐oxygenated double‐layered hydrogel under natural light for real‐time infection monitoring, enhanced photodynamic therapy, and hypoxia relief in refractory diabetic wounds healing | |
Abrigo et al. | Electrospun nanofibers as dressings for chronic wound care: advances, challenges, and future prospects | |
CN104906623B (zh) | 一种纤维素基敷料及其制备方法和应用 | |
CN113246468B (zh) | 一种生物活性医用敷料的制备方法 | |
CN107185031A (zh) | 一种具有生物活性的医用敷料及其制备方法 | |
US20200069482A1 (en) | pH Indicator Dressing for Monitoring of Wound and Infection | |
CN115487337B (zh) | 一种皮肤修复用敷料贴及其制备方法 | |
CN103083712A (zh) | 掺入有干细胞或其它生物活性物质的外科敷料 | |
CN111973800A (zh) | 一种载药缓释水凝胶及其制备方法与用途 | |
CN108498855B (zh) | 一种抗菌止血溶胶及其制备方法 | |
CN112587717A (zh) | 一种金属阳离子交联海藻酸盐/细菌纤维素复合水凝胶抗菌敷料 | |
Huang et al. | A multifunctional 3D dressing unit based on the core–shell hydrogel microfiber for diabetic foot wound healing | |
Li et al. | Dissolving microneedles based on ZnO nanoparticles and an ionic liquid as synergistic antibacterial agents | |
CN113244438B (zh) | 一种三维糖尿病足溃疡功能性医用敷料的制备方法 | |
CN114225090A (zh) | 一种具有粘附性和抗菌性能的壳聚糖基纳米纤维伤口敷料及其制备方法 | |
CN111773433B (zh) | 一种载药纳米气泡骨水泥的制备方法 | |
RU2286800C1 (ru) | Антибактериальный наполнитель для женской гигиенической прокладки или тампона, способ его получения и использования | |
CN108354951A (zh) | 一种促进创口愈合的富氧凝胶剂、制备方法及应用 | |
CN106562953A (zh) | 羟基红花黄色素a在制备治疗糖尿病足溃疡的药物中的应用、药物及药物制备方法 | |
CN218552772U (zh) | 一种皮肤修复用敷料贴 | |
CN114917394B (zh) | 一种双层载纳米银和生长因子的复合功能性敷料及其制备方法 | |
CN114832142B (zh) | 一种壳聚糖复合敷料及其制备方法 | |
Shi et al. | Spatially engineering tri-layer nanofiber dressings featuring asymmetric wettability for wound healing | |
CN112915252B (zh) | 一种壳聚糖季铵盐衍生物创面敷料及其制备方法 | |
CN115040773B (zh) | 一种治疗慢性感染创面的微针贴片及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240111 Address after: Room E402D, Taiwan Science and Technology Enterprise Development Center, No. 88, Xiangxing Road, Xiang'an Torch High tech Zone, Xiamen, Fujian Province, 361115 Patentee after: Bencao Fu (Xiamen) New Material Technology Co.,Ltd. Address before: Room 801, 85 Kefeng Road, Huangpu District, Guangzhou City, Guangdong Province Patentee before: Yami Technology (Guangzhou) Co.,Ltd. Effective date of registration: 20240111 Address after: Room 801, 85 Kefeng Road, Huangpu District, Guangzhou City, Guangdong Province Patentee after: Yami Technology (Guangzhou) Co.,Ltd. Address before: No.22, Dongcheng village, Pengjiang district, Jiangmen City, Guangdong Province Patentee before: WUYI University |